293 related articles for article (PubMed ID: 33616817)
21. Letter regarding - Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study.
Theodorou DJ; Theodorou SJ; Tzimas V; Korompilias AV
Bone; 2023 Oct; 175():116853. PubMed ID: 37473932
[No Abstract] [Full Text] [Related]
22. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
[TBL] [Abstract][Full Text] [Related]
23. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
Gong LH; Liu WF; Ding Y; Zhang W; Yang YK; Yu F; Wong GQ; Huang XY; Niu XH
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):449-454. PubMed ID: 29886590
[No Abstract] [Full Text] [Related]
24. A case of pelvic giant cell tumor of bone, complete remission with denosumab: long duration of response.
Bilgetekin I; Mammadkhanli O; Basal FB; Kandemir O; Canbay S; Oksuzoglu B
Anticancer Drugs; 2020 Jun; 31(5):533-535. PubMed ID: 31743134
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
Rosario M; Takeuchi A; Yamamoto N; Hayashi K; Miwa S; Higuchi T; Abe K; Taniguchi Y; Aiba H; Tanzawa Y; Murakami H; Tsuchiya H
Anticancer Res; 2017 Feb; 37(2):749-754. PubMed ID: 28179326
[TBL] [Abstract][Full Text] [Related]
26. Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results.
Palmerini E; Ruggieri P; Angelini A; Boriani S; Campanacci D; Milano GM; Cesari M; Paioli A; Longhi A; Abate ME; Scoccianti G; Terzi S; Trovarelli G; Franchi A; Picci P; Ferrari S; Leopardi MP; Pierini M
Tumori; 2018 Oct; 104(5):344-351. PubMed ID: 30086700
[TBL] [Abstract][Full Text] [Related]
27. Current management of giant-cell tumor of bone in the denosumab era.
Nagano A; Urakawa H; Tanaka K; Ozaki T
Jpn J Clin Oncol; 2022 May; 52(5):411-416. PubMed ID: 35199172
[TBL] [Abstract][Full Text] [Related]
28. Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Meier ME; Clerkx SN; Winter EM; Pereira AM; van de Ven AC; van de Sande MAJ; Appelman-Dijkstra NM
J Bone Miner Res; 2021 Sep; 36(9):1729-1738. PubMed ID: 34076303
[TBL] [Abstract][Full Text] [Related]
29. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature.
Luengo-Alonso G; Mellado-Romero M; Shemesh S; Ramos-Pascua L; Pretell-Mazzini J
Arch Orthop Trauma Surg; 2019 Oct; 139(10):1339-1349. PubMed ID: 30877429
[TBL] [Abstract][Full Text] [Related]
30. Denosumab for giant cell tumors of bone from 2010 to 2022: a bibliometric analysis.
Tan X; Zhang Y; Wei D; Yang Y; Xiang F
Clin Exp Med; 2023 Nov; 23(7):3053-3075. PubMed ID: 37103655
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
[TBL] [Abstract][Full Text] [Related]
32. How safe and effective is denosumab for bone giant cell tumour?
Errani C; Tsukamoto S; Mavrogenis AF
Int Orthop; 2017 Nov; 41(11):2397-2400. PubMed ID: 28646421
[TBL] [Abstract][Full Text] [Related]
33. Treatment of fibrous dysplasia: focus on denosumab.
Huzum B; Antoniu S; Dragomir R
Expert Opin Biol Ther; 2022 Mar; 22(3):397-405. PubMed ID: 34964677
[TBL] [Abstract][Full Text] [Related]
34. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.
Park MJ; Ganjoo KN; Ladd AL
J Hand Surg Am; 2015 Aug; 40(8):1620-4. PubMed ID: 25935517
[TBL] [Abstract][Full Text] [Related]
35. Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.
Tsukamoto S; Mavrogenis AF; Leone G; Righi A; Akahane M; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
Int Orthop; 2019 Feb; 43(2):483-489. PubMed ID: 30099641
[TBL] [Abstract][Full Text] [Related]
36. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA
Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
[TBL] [Abstract][Full Text] [Related]
37. Surgical Management and Denosumab for Aneurysmal Bone Cysts of the Spine in an Australian Tertiary Paediatric Centre.
Vanderniet JA; Tsinas D; Wall CL; Girgis CM; London K; Keane C; Briody J; Hibbert S; Poon M; Padhye B; Biggin A; Dalla-Pozza L; Gray RJ; Munns CF
Calcif Tissue Int; 2023 May; 112(5):592-602. PubMed ID: 36810677
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation.
Kerr DA; Brcic I; Diaz-Perez JA; Shih A; Wilky BA; Pretell-Mazzini J; Subhawong TK; Nielsen GP; Rosenberg AE
Am J Surg Pathol; 2021 Jan; 45(1):93-100. PubMed ID: 32773532
[TBL] [Abstract][Full Text] [Related]
39. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
Chawla S; Blay JY; Rutkowski P; Le Cesne A; Reichardt P; Gelderblom H; Grimer RJ; Choy E; Skubitz K; Seeger L; Schuetze SM; Henshaw R; Dai T; Jandial D; Palmerini E
Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134
[TBL] [Abstract][Full Text] [Related]
40. Current concepts in the treatment of giant cell tumour of bone.
van der Heijden L; Dijkstra S; van de Sande M; Gelderblom H
Curr Opin Oncol; 2020 Jul; 32(4):332-338. PubMed ID: 32541321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
